![Theodore Schroeder](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Theodore Schroeder
Director/Miembro de la Junta en CIDARA THERAPEUTICS, INC. .
Fortuna: 17 604 $ al 31/05/2024
Perfil
Mr. Theodore R.
Schroeder is an Independent Director at Cidara Therapeutics, Inc. He is on the Board of Directors at Nabriva Therapeutics Plc, BIOCOM, Cidara Therapeutics, Inc. and Sharp Hospital Foundation.
Mr. Schroeder was previously employed as a Chairman by Antimicrobials Working Group, an Independent Director by Collegium Pharmaceutical, Inc., an Independent Director by Otonomy, Inc., a President, Chief Executive Officer & Director by Zavante Therapeutics, Inc., an Independent Director by Trius Therapeutics, Inc., a President, Chief Executive Officer & Director by Cadence Pharmaceuticals, Inc., a Senior VP-North American Sales & Marketing by Elan Pharmaceuticals, Inc., a Senior Director-Marketing Hospital Products by Dura Pharmaceuticals, Inc., and a Principal by Bristol Myers Squibb Co. He also served on the board at Hyperion Therapeutics, Inc. and Incline Therapeutics, Inc. He received his undergraduate degree from Rutgers State University of New Jersey.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
NABRIVA THERAPEUTICS PLC
0.39% | 31/01/2023 | 12 397 ( 0.39% ) | 17 604 $ | 31/07/2023 |
28/05/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Cargos activos de Theodore Schroeder
Empresas | Cargo | Inicio |
---|---|---|
CIDARA THERAPEUTICS, INC. | Director/Miembro de la Junta | 01/04/2014 |
NABRIVA THERAPEUTICS PLC | Director/Miembro de la Junta | 01/08/2018 |
Sharp Hospital Foundation | Director/Miembro de la Junta | - |
BIOCOM
![]() BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Director/Miembro de la Junta | 27/02/2017 |
Antiguos cargos conocidos de Theodore Schroeder.
Empresas | Cargo | Fin |
---|---|---|
OTONOMY | Director/Miembro de la Junta | 15/02/2023 |
Antimicrobials Working Group
![]() Antimicrobials Working Group Miscellaneous Commercial ServicesCommercial Services Antimicrobials Working Group is an American nonprofit company. The firm operates as an association of antimicrobials and diagnostics companies. The company says this about itself: AWG was founded in 2012 with the vision of utilizing collective power to improve the regulatory, investment, and commercial environment for emerging infectious disease companies. Today, AWG is comprised of thirteen antimicrobials companies: Acurx Pharmaceuticals, Inc., Cidara Therapeutics Inc., CorMedix Inc., Crestone, Inc., Entasis Therapeutics Inc., Iterum Therapeutics Ltd., Melinta Therapeutics LLC, Nabriva Therapeutics US Inc., Paratek Pharmaceuticals Inc., Qpex Biopharma, Inc., SCYNEXIS Inc., UTILITY therapeutics Ltd., and Venatorx Pharmaceuticals, Inc. | Presidente | 17/01/2023 |
COLLEGIUM PHARMACEUTICAL, INC. | Director/Miembro de la Junta | 21/05/2021 |
Zavante Therapeutics, Inc.
![]() Zavante Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Zavante Therapeutics, Inc. manufactures pharmaceutical products. Its product ZOLYD is an investigational, first-in-class epoxide antibiotic with a spectrum of bactericidal Gram-negative and Gram-positive activity, including activity against most contemporary MDR strains that threaten hospitalized patients. The company was founded by Cam L. Garner, Evelyn Ellis-Grosse and Theodore R. Schroeder in 2013 and is headquartered in San Diego, CA. | Fundador | 24/07/2018 |
HYPERION THERAPEUTICS INC | Director/Miembro de la Junta | 07/05/2015 |
Formación de Theodore Schroeder.
Rutgers State University of New Jersey | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 4 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
COLLEGIUM PHARMACEUTICAL, INC. | Health Technology |
CIDARA THERAPEUTICS, INC. | Health Technology |
NABRIVA THERAPEUTICS PLC | Health Technology |
Empresas privadas | 11 |
---|---|
Dura Pharmaceuticals, Inc.
![]() Dura Pharmaceuticals, Inc. BiotechnologyHealth Technology Dura Pharmaceuticals, Inc. markets and sells prescription products that treat infectious and respiratory diseases. Dura focuses on products and transactions that leverage its sales and marketing organization. Dura also intends, through the use of collaborative relationships, to develop the Spiros® motorized blisterdisk and Spiros® S2 pulmonary drug delivery systems for the local and systemic delivery of a wide range of medications. It is located in San Diego, CA. | Health Technology |
Elan Pharmaceuticals, LLC
![]() Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Health Technology |
Hyperion Therapeutics, Inc.
![]() Hyperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Hyperion Therapeutics, Inc. developed and commercialized pharmaceutical products. The company was founded by Mark Blumling and Christopher Eugene Rivera on November 1, 2006 and headquartered in Brisbane, CA. | Health Technology |
Incline Therapeutics, Inc.
![]() Incline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Incline Therapeutics, Inc. develops pharmaceutical products. The firm operates as hospital-focused specialty pharmaceutical company focused on the development of IONSYS (fentanyl iontophoretic transdermal system). The company was founded in 2009 and is headquartered in Seatle, WA. | Health Technology |
Mallinckrodt Hospital Products, Inc.
![]() Mallinckrodt Hospital Products, Inc. Pharmaceuticals: MajorHealth Technology Mallinckrodt Hospital Products, Inc. operates as a biopharmaceutical company, which develops and commercializes proprietary product candidates used in the hospital setting. The firm offers OFIRMEV (acetaminophen injection), a proprietary intravenous formulation of acetaminophen for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics and the reduction of fever. The company was founded by Theodore R. Schroeder, David A. Socks, and Cam L. Garner on May 26, 2004 and is headquartered in Hazelwood, MO. | Health Technology |
BIOCOM
![]() BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Commercial Services |
Trius Therapeutics, Inc.
![]() Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trius Therapeutics, Inc. is a biopharmaceutical company which focuses on the discovery, development and commercialization of innovative antibiotics for life-threatening infections. It engages in developing tedizolid phosphate an intravenous, or IV, and oral antibiotic, for the treatment of serious gram-positive bacterial infections, initially for acute bacterial skin and skin structure infections, ABSSSI, and subsequently for other indications, including pneumonia. ABSSSI is a new classification for complicated skin and skin structure infections, or cSSSI. Tedizolid phosphate is an IV and orally administered second generation oxazolidinone. The company develops antibiotics for gram-negative infections. Trius Therapeutics was founded by John Finn and John P. Schmid in June 2004, and is headquartered in San Diego, CA. | Health Technology |
Sharp Hospital Foundation | |
Otonomy, Inc.
![]() Otonomy, Inc. BiotechnologyHealth Technology Otonomy, Inc. operates as a biopharmaceutical company. engages in the development of therapeutics for neurotology. The firm’s product pipeline includes OTIVIDEX (dexamethasone) Meniere's disease, OTIPRIO (ciprofloxacin otic suspension) acute otitis media with tubes (AOMT), OTO-313 (gacyclidine) tinnitus, OTO-413 (BDNF) hidden hearing Loss, OTO-510 (otoprotectant) prevent CIHL, OTO-6XX (hair cell regeneration) severe hearing loss. It operates under the Otiprio brand. The company was founded by Jay B. Lichter, Jeffrey Harris, Rick Friedman, and Allen F. Ryan on May 6, 2008 and is headquartered in San Diego, CA. | Health Technology |
Zavante Therapeutics, Inc.
![]() Zavante Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Zavante Therapeutics, Inc. manufactures pharmaceutical products. Its product ZOLYD is an investigational, first-in-class epoxide antibiotic with a spectrum of bactericidal Gram-negative and Gram-positive activity, including activity against most contemporary MDR strains that threaten hospitalized patients. The company was founded by Cam L. Garner, Evelyn Ellis-Grosse and Theodore R. Schroeder in 2013 and is headquartered in San Diego, CA. | Health Technology |
Antimicrobials Working Group
![]() Antimicrobials Working Group Miscellaneous Commercial ServicesCommercial Services Antimicrobials Working Group is an American nonprofit company. The firm operates as an association of antimicrobials and diagnostics companies. The company says this about itself: AWG was founded in 2012 with the vision of utilizing collective power to improve the regulatory, investment, and commercial environment for emerging infectious disease companies. Today, AWG is comprised of thirteen antimicrobials companies: Acurx Pharmaceuticals, Inc., Cidara Therapeutics Inc., CorMedix Inc., Crestone, Inc., Entasis Therapeutics Inc., Iterum Therapeutics Ltd., Melinta Therapeutics LLC, Nabriva Therapeutics US Inc., Paratek Pharmaceuticals Inc., Qpex Biopharma, Inc., SCYNEXIS Inc., UTILITY therapeutics Ltd., and Venatorx Pharmaceuticals, Inc. | Commercial Services |
- Bolsa de valores
- Insiders
- Theodore Schroeder